FOLH1 and prostate neoplasm: A previous study of Ruigrok et al. revealed that although 177Lu-PSMA-617 and 177Lu-PSMA-I&T show similar binding characteristics in prostate tumors, 177Lu PSMA-I&T has a lower tumor-to-kidney ratio than 177Lu PSMA-617 [104].